RxSight, Inc. Common Stock RXST
i
Market dataready · fetched 2026-11-11T15:54:46.904Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:51:57.511478163Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T15:54:46.571432+00:00
RxSight, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 3.00 | 461.8% | 46.0% | |||
| 25Δ | 3.30 | 407.6% | 39.9% | |||
| 30Δ | 7.44 | 331.9% | 60.6% | 3.60 | 353.4% | 33.8% |
| 35Δ | 6.85 | 290.0% | 48.7% | 3.90 | 299.2% | 27.6% |
| 40Δ | 6.26 | 248.1% | 36.9% | 4.19 | 245.0% | 21.5% |
| 45Δ | 5.67 | 206.2% | 25.1% | 4.49 | 190.8% | 15.4% |
| 50Δ | 5.09 | 164.2% | 13.2% | 4.79 | 136.6% | 9.3% |
| 55Δ | 4.75 | 177.4% | 10.6% | |||
| 60Δ | 4.45 | 200.1% | 9.5% | |||
| 65Δ | 4.16 | 222.8% | 8.4% | |||
| 70Δ | 3.86 | 245.6% | 7.3% | |||
| 75Δ | 3.57 | 268.3% | 6.2% | |||
| 80Δ | 3.27 | 291.0% | 5.1% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.00
- IV
- 461.8%
- B/E move
- 46.0%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.30
- IV
- 407.6%
- B/E move
- 39.9%
30Δ
- Pseudo strike
- 7.44
- IV
- 331.9%
- B/E move
- 60.6%
- Pseudo strike
- 3.60
- IV
- 353.4%
- B/E move
- 33.8%
35Δ
- Pseudo strike
- 6.85
- IV
- 290.0%
- B/E move
- 48.7%
- Pseudo strike
- 3.90
- IV
- 299.2%
- B/E move
- 27.6%
40Δ
- Pseudo strike
- 6.26
- IV
- 248.1%
- B/E move
- 36.9%
- Pseudo strike
- 4.19
- IV
- 245.0%
- B/E move
- 21.5%
45Δ
- Pseudo strike
- 5.67
- IV
- 206.2%
- B/E move
- 25.1%
- Pseudo strike
- 4.49
- IV
- 190.8%
- B/E move
- 15.4%
50Δ
- Pseudo strike
- 5.09
- IV
- 164.2%
- B/E move
- 13.2%
- Pseudo strike
- 4.79
- IV
- 136.6%
- B/E move
- 9.3%
55Δ
- Pseudo strike
- 4.75
- IV
- 177.4%
- B/E move
- 10.6%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 4.45
- IV
- 200.1%
- B/E move
- 9.5%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 4.16
- IV
- 222.8%
- B/E move
- 8.4%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 3.86
- IV
- 245.6%
- B/E move
- 7.3%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 3.57
- IV
- 268.3%
- B/E move
- 6.2%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 3.27
- IV
- 291.0%
- B/E move
- 5.1%
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Medical Devices
SENS
Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe,…
More →SGHT
Sight Sciences Inc. (SGHT) is an innovative medical technology company specializing in the advancement of treatments for ocular diseases, with a particular emphasis on glaucoma…
More →SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and internationally. The…
More →SNN
Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
More →SRTS
Description unavailable
More →STE
Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system.
More →